Severe bone pain as an adverse effect of cyclosporin therapy for Crohn's disease

Inflammatory Bowel Diseases

Volumn 4, Issue 2, 1998, Pages 95-97

  Isaacs, Kim L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Division of Digestive Diseases   (United States)

Author keywords

Bone pain; Crohn's disease; Cyclosporin; Side effect

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BONE DISEASE; CASE REPORT; CROHN DISEASE; HOSPITALIZATION; HUMAN; LEG; MALE; PAIN; PATHOPHYSIOLOGY;

ADULT; BONE DISEASES; CROHN DISEASE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEG; MALE; PAIN; SEVERITY OF ILLNESS INDEX;

EID: 0032066299     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780040205     Document Type: Article

References (11)

1. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 1994;330:1841-5.
2. Brynskov J, Freund L, Rasmussen SN, Lauritsen K, de Muckadell OS, Williams M, MacDonald AS, Tanton R, Molina F. A placebo controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50.
3. Feagan BG, McDonald JWD, Rochon J, Laupacis A, Fedorak R, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R, Valberg B, Irvine EJ. Low-dose cyclosporin for the treatment of Crohn's disease. N Engl J Med 1994;330:1846-51.
4. Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflammatory Bowel Diseases 1995;1:48-63.
5. Harris DT, Kozumbo WJ, Cerutti PA, Cerottini JC. Mechanisms of cyclosporin A-induced immunosuppression: cyclosporin A inhibits receptor-mediated and non-receptor mediated lymphokine production as well as interleukin-2 proliferation in cloned T lymphocytes. Cell Immunol 1987;109:104-14.
6. Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
7. Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz LL, Augustine JE, Raymer JM, Romero JC, Weisner RH, Krom RA, Burnett J. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994;69:1182-93.
8. Gauthier VJ, Barbosa LM. Bone pain in transplant recipients responsive to calcium channel blockers. Ann Intern Med 1994;121: 863-5.
9. Lucas V, Hourmant M, Soulillou JP, Rossard A, Prost A. Douleurs osseuses epiphysaires rapportees a la ciclosporine A chez 28 transplantes renaux. Rev Rhum Mal Osteoartic 1990;57:79-84.
10. Munoz-Gomez J, Collado A, Gratacos J, Campistol JM, Lomena F, Llena J, Andreu J. Reflex sympathetic dystrophy of the lower limbs in renal transplant patients treated with cyclosporin A. Arthritis Rheum 1991;34:625-30.
11. Barbosa LM, Gauthier VJ, Davis CL. Bone pain that responds to calcium channel blockers: a retrospective and prospective study of transplant recipients. Transplantation 1995;59:541-4.